The differences between batch processing and continuous manufacturing of biologics require a detailed understanding of material traceability and the effects of perturbations on material quality.
At the just completed BioProcess International Conference in Boston, a number of sessions focused on the Bioprocess 4.0 trend toward continuous bioprocessing operations. Akshat Mullerpatan, PhD, ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果